The fetal insulin hypothesis: an alternative explanation of the association of low bir thweight with diabetes and vascular disease

Barker, 1990, Fetal and placental size and risk of hypertension in adult life, BMJ, 301, 259, 10.1136/bmj.301.6746.259

Barker, 1992, The relation of fetal length, ponderal index and head circumference to blood pressure and the risk of hypertension in adult life, Paediatr Perinat Epidemiol, 6, 35, 10.1111/j.1365-3016.1992.tb00741.x

Hales, 1991, Fetal and infant growth and impaired glucose tolerance at age 64, BMJ, 303, 1019, 10.1136/bmj.303.6809.1019

Phipps, 1993, Fetal growth and impaired glucose tolerance in men and women, Diabetologia, 36, 225, 10.1007/BF00399954

Yajnik, 1995, Fetal growth and glucose and insulin metabolism in four-year-old Indian children, Diabet Med, 12, 330, 10.1111/j.1464-5491.1995.tb00487.x

Law, 1995, Thinness at birth and glucose tolerance in seven-year-old children, Diabet Med, 12, 24, 10.1111/j.1464-5491.1995.tb02057.x

Clausen, 1997, Relation between birth weight and the insulin sensitivity index in a population sample of 331 young, healthy Caucasians, Am J Epidemiol, 146, 23, 10.1093/oxfordjournals.aje.a009188

Hales, 1994, The pathogenesis of NIDDM, Diabetologia, 37, S162, 10.1007/BF00400840

Barker, 1995, Intrauterine programming of adult disease, Mol Med Today, 1, 418, 10.1016/S1357-4310(95)90793-9

Pederson, 1977, Hyperglycaemia-hyperinsulinism theory and birthweight, 211

Naylor, 1996, Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators, JAMA, 275, 1165, 10.1001/jama.1996.03530390031030

Tallarigo, 1986, Relation of glucose tolerance to complications of pregnancy in nondiabetic women, N Engl J Med, 315, 989, 10.1056/NEJM198610163151603

Farmer, 1988, The influence of maternal glucose metabolism on fetal growth, development and morbidity in 917 singlet on pregnancies in nondiabetic women, Diabetologia, 31, 134, 10.1007/BF00276845

Breshi, 1993, Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy, Diabetologia, 36, 1315, 10.1007/BF00400812

Sermer, 1995, Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: the Toronto Tri-Hospital Gestational Diabetes Project, Am J Obstet Gynecol, 173, 146, 10.1016/0002-9378(95)90183-3

Froguel, 1993, Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus, N Engl J Med, 328, 697, 10.1056/NEJM199303113281005

Byrne, 1994, Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations, J Clin Invest, 93, 1120, 10.1172/JCI117064

Hattersley, 1998, Mutations in the glucokinase gene of the fetus result in reduced birth weight, Nat Genet, 19, 268, 10.1038/953

Stoffers, 1997, Pancreatic agenesis attributable to a single nucleotidedeletion in the human IPF1 gene coding sequence, Nat Genet, 15, 106, 10.1038/ng0197-106

Wright, 1993, Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis, Am J Dis Child, 147, 607

Temple, 1995, An imprinted gene(s) for diabetes?, Nat Genet, 9, 110, 10.1038/ng0295-110

Temple, 1996, Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23, Hum Mol Genet, 5, 1117, 10.1093/hmg/5.8.1117

Shield, 1996, Neonatal diabetes, 681

Thomas, 1995, Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy, Science, 268, 426, 10.1126/science.7716548

Thomas, 1996, Mutation of the pancreatic islet inward rectifier Kir 62 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy, Hum Mol Genet, 5, 1809, 10.1093/hmg/5.11.1809

Aparicio, 1993, Prenatal diagnosis of familial neonatal hyperinsulinemia, Acta Paediatr, 83, 683, 10.1111/j.1651-2227.1993.tb18040.x

Elsas, 1985, Leprechaunism: an inherited defect in a high-affinity insulin receptor, Am J Hum Genet, 37, 73

Donohue, 1954, Leprechaunism: a euphenism for a rare familial disorder, J Pediatr, 45, 505, 10.1016/S0022-3476(54)80113-2

Matschinsky, 1993, Glucokinase as pancreatic beta cell glucose sensor and diabetes gene, J Clin Invest, 92, 2092, 10.1172/JCI116809

Hattersley, 1998, Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity, Diabet Med, 15, 15, 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M

Hseuh, 1997, Endothelium in insulin resistance and diabetes, Diabet Rev, 5, 343

Steinberg, 1994, Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release, J Clin Invest, 94, 1172, 10.1172/JCI117433

Hudlicka, 1992, Angiogenesis in skeletal and cardiac muscle, Physiol Rev, 72, 369, 10.1152/physrev.1992.72.2.369

Feener, 1997, Vascular dysfunction in diabetes mellitus, Lancet, 350, S19

Noon, 1997, Impaired microvascular dilatation and capllary rarefaction in young adults with a predisposition to high blood pressure, J Clin Invest, 99, 1873, 10.1172/JCI119354

Serné, 1997, Insulin resistance and hypertension: role for microcirculation?, Diabetologia, 40, A256

Chapman, 1997, Retinal vascular network architecture in low-birth-weight men, J Hypertens, 15, 1449, 10.1097/00004872-199715120-00012

Law, 1992, Early growth and abdominal fatness in adult life, J Epidemiol Community Health, 46, 184, 10.1136/jech.46.3.184

van der Poll, 1992, Tumour necrosis factor induces von Willebrand factor release in healthy humans, Thromb Haemost, 67, 623, 10.1055/s-0038-1648512

Kroder, 1996, Tumor necrosis factor-α-and hyperglycemia-induced insulin resistance, J Clin Invest, 97, 1471, 10.1172/JCI118569

Shimomura, 1996, Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity, Nat Med, 2, 800, 10.1038/nm0796-800

Phillips, 1995, Fetal growth and insulin resistance in adult life: role of plasma triglyceride and nonesterified fatty acids, Diabet Med, 12, 796, 10.1111/j.1464-5491.1995.tb02082.x

Sherman, 1998, Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension, Clin Sci, 94, 373, 10.1042/cs0940373